This document discusses anesthesia considerations for obstetric hemorrhage. It provides statistics on causes of maternal mortality, including that obstetric hemorrhage accounts for 67.4% of maternal deaths in Vietnam. Common causes of obstetric hemorrhage are uterine atony, retained placenta, abnormal placentation. Risk factors include previous cesarean sections, placenta previa, and placenta accreta. Treatment involves medical uterotonics, blood transfusion, and in severe cases, hysterectomy. Anesthesia management includes anticipating blood loss and having blood products available.
Obstetric haemorrhage is a leading cause of maternal mortality. It can be classified as antepartum or postpartum haemorrhage. Antepartum haemorrhage includes conditions like placenta previa and placental abruption. Placenta previa occurs when the placenta implants in the lower uterine segment, and can cause painless bleeding. Caesarean section is usually required for delivery. General anaesthesia is preferred but regional anaesthesia can be used if the patient is haemodynamically stable. Uterine atony is a major cause of postpartum haemorrhage. Oxytocin is first-line treatment but other uterotonics may
This document discusses anaesthetic management for antepartum haemorrhage (APH) due to placenta previa or abruption. It begins by defining APH and describing the two main causes as placenta previa and abruption. For abruption, it notes that general anaesthesia is preferred due to the high risk of postpartum haemorrhage. For placenta previa, spinal or epidural anaesthesia can be considered if the patient is stable and accreta has been ruled out, otherwise general anaesthesia is used. The document provides detailed guidelines for anaesthetic management in massive bleeding situations, emphasizing fluid replacement, blood product transfusion, and being prepared for potential interventions like embol
Anaesthetic management of obstetric emergenciesVidhi Gajjar
This document discusses the anesthetic management of obstetric emergencies such as major obstetric hemorrhage and fetal compromise. It covers the challenges in managing obstetric hemorrhage including difficulty in estimating blood loss and early diagnosis of shock due to masking of signs by normal pregnancy physiology. The management approach "ORDER" is outlined which includes organization, resuscitation, defective coagulation, evaluation of response, and remedying the cause of bleeding. General anesthesia techniques for cesarean sections in hemorrhage emphasize rapid sequence induction, cricoid pressure, and hemodynamic support through fluid resuscitation and blood product transfusion to maintain coagulation.
This document discusses several common obstetric emergencies including sudden maternal collapse, massive obstetric hemorrhage, prolonged pregnancy, and sepsis. It provides details on the definition, risk factors, signs and symptoms, and management approaches for each emergency. Key points covered include initial steps to manage maternal collapse addressing the ABCDE approach, definitions and causes of antepartum and postpartum hemorrhage, signs of sepsis and use of early warning systems, and induction of labor recommendations for prolonged pregnancy over 42 weeks.
Massive obstetric haemorrhage is a leading cause of maternal mortality. It can occur without warning at any stage of pregnancy or childbirth. Early recognition and treatment is essential to prevent severe blood loss. A multidisciplinary team approach is needed to resuscitate the mother and determine the source of bleeding to apply appropriate medical or surgical interventions.
This document discusses various obstetric emergencies that may require immediate cesarean delivery, including fetal distress, placental abruption, placenta previa, and uterine rupture. It provides information on anesthesia considerations for emergency cesarean sections, including the choice between regional (epidural or spinal) versus general anesthesia based on urgency, maternal volume status, and coagulation status. Risks of general anesthesia are generally higher than regional anesthesia for cesarean deliveries. The document also reviews complications of placenta previa, placenta accreta, retained placenta, and uterine atony that may require treatment.
This document discusses postpartum haemorrhage (PPH), defined as blood loss exceeding 500 ml following childbirth. It notes that PPH has various causes including an atonic uterus, trauma during delivery, retained placental tissues, and coagulation disorders. The primary types are those occurring within 24 hours of delivery. Management involves controlling blood loss, administering oxytocics, and may require interventions like uterine packing or hysterectomy in severe cases. Prevention strategies include active management of the third stage of labour and being prepared to treat PPH as a potential complication of childbirth.
Obstetric haemorrhage is a leading cause of maternal mortality. It can be classified as antepartum or postpartum haemorrhage. Antepartum haemorrhage includes conditions like placenta previa and placental abruption. Placenta previa occurs when the placenta implants in the lower uterine segment, and can cause painless bleeding. Caesarean section is usually required for delivery. General anaesthesia is preferred but regional anaesthesia can be used if the patient is haemodynamically stable. Uterine atony is a major cause of postpartum haemorrhage. Oxytocin is first-line treatment but other uterotonics may
This document discusses anaesthetic management for antepartum haemorrhage (APH) due to placenta previa or abruption. It begins by defining APH and describing the two main causes as placenta previa and abruption. For abruption, it notes that general anaesthesia is preferred due to the high risk of postpartum haemorrhage. For placenta previa, spinal or epidural anaesthesia can be considered if the patient is stable and accreta has been ruled out, otherwise general anaesthesia is used. The document provides detailed guidelines for anaesthetic management in massive bleeding situations, emphasizing fluid replacement, blood product transfusion, and being prepared for potential interventions like embol
Anaesthetic management of obstetric emergenciesVidhi Gajjar
This document discusses the anesthetic management of obstetric emergencies such as major obstetric hemorrhage and fetal compromise. It covers the challenges in managing obstetric hemorrhage including difficulty in estimating blood loss and early diagnosis of shock due to masking of signs by normal pregnancy physiology. The management approach "ORDER" is outlined which includes organization, resuscitation, defective coagulation, evaluation of response, and remedying the cause of bleeding. General anesthesia techniques for cesarean sections in hemorrhage emphasize rapid sequence induction, cricoid pressure, and hemodynamic support through fluid resuscitation and blood product transfusion to maintain coagulation.
This document discusses several common obstetric emergencies including sudden maternal collapse, massive obstetric hemorrhage, prolonged pregnancy, and sepsis. It provides details on the definition, risk factors, signs and symptoms, and management approaches for each emergency. Key points covered include initial steps to manage maternal collapse addressing the ABCDE approach, definitions and causes of antepartum and postpartum hemorrhage, signs of sepsis and use of early warning systems, and induction of labor recommendations for prolonged pregnancy over 42 weeks.
Massive obstetric haemorrhage is a leading cause of maternal mortality. It can occur without warning at any stage of pregnancy or childbirth. Early recognition and treatment is essential to prevent severe blood loss. A multidisciplinary team approach is needed to resuscitate the mother and determine the source of bleeding to apply appropriate medical or surgical interventions.
This document discusses various obstetric emergencies that may require immediate cesarean delivery, including fetal distress, placental abruption, placenta previa, and uterine rupture. It provides information on anesthesia considerations for emergency cesarean sections, including the choice between regional (epidural or spinal) versus general anesthesia based on urgency, maternal volume status, and coagulation status. Risks of general anesthesia are generally higher than regional anesthesia for cesarean deliveries. The document also reviews complications of placenta previa, placenta accreta, retained placenta, and uterine atony that may require treatment.
This document discusses postpartum haemorrhage (PPH), defined as blood loss exceeding 500 ml following childbirth. It notes that PPH has various causes including an atonic uterus, trauma during delivery, retained placental tissues, and coagulation disorders. The primary types are those occurring within 24 hours of delivery. Management involves controlling blood loss, administering oxytocics, and may require interventions like uterine packing or hysterectomy in severe cases. Prevention strategies include active management of the third stage of labour and being prepared to treat PPH as a potential complication of childbirth.
1. Obstetric emergencies include antepartum and postpartum hemorrhage from conditions like placenta previa, placental abruption, and uterine rupture.
2. Placenta previa is when the placenta implants in the lower uterine segment, potentially blocking the cervix and causing painless bleeding late in pregnancy.
3. Anesthetic management for placenta previa and other hemorrhages involves ensuring large bore IV access, blood product availability, and invasive monitoring while determining the need for general or neuraxial anesthesia depending on maternal stability.
1. Antepartum haemorrhage (APH) refers to vaginal bleeding after 24 weeks of gestation and can endanger the lives of the mother and fetus. The most common causes are placenta previa and abruptio placentae.
2. Abruptio placentae involves premature separation of the placenta and can range from minor to major/life-threatening. General anaesthesia is recommended even in stable patients due to high risk of postpartum haemorrhage.
3. Placenta previa occurs when the placenta implants in the lower uterine segment, potentially causing painless bleeding. Grading depends on proximity to the cervical os. Spinal
This document discusses postpartum hemorrhage, including definition, risk factors, diagnosis, and treatment. It begins with two case examples of women experiencing heavy bleeding after delivery. The main causes of postpartum hemorrhage - uterine atony, retained placenta, lacerations, and coagulation disorders - are reviewed. Treatment focuses on the "four Ts": addressing tone with uterotonic drugs, checking for retained tissue, repairing any trauma, and evaluating for thrombin abnormalities. Early diagnosis and treatment are important to prevent severe bleeding and potential mortality from postpartum hemorrhage.
This document summarizes causes, risk factors, diagnosis, and management of postpartum hemorrhage (PPH). PPH is defined as blood loss of 500 ml or more within 24 hours of delivery. Common causes include uterine atony (70%), retained placenta, genital tract trauma, and bleeding disorders. Risk factors include previous uterine surgery, uterine abnormalities, and operative delivery. Diagnosis involves estimating blood loss and identifying the cause. Management involves resuscitation, arresting the bleeding through uterotonic drugs, manual removal of retained placenta, repairing lacerations, and in severe cases, surgical procedures like hysterectomy.
This document summarizes several obstetric emergencies, including classifications, approaches, and management strategies. Obstetric emergencies can be maternal or fetal and include hemorrhage, hypertension, uterine rupture, and cord prolapse. The structured ABC approach is recommended to initially assess and stabilize all emergency patients. Specific conditions like placenta previa require monitoring or delivery depending on bleeding and gestational age. Overall the document provides an overview of evaluating and treating common high-risk pregnancies and deliveries.
Postpartum haemorrhage (PPH) is the leading cause of maternal mortality worldwide, accounting for 25-50% of deaths. PPH is defined as blood loss of 500ml or more within 24 hours of delivery. Uterine atony is the most common cause, occurring in 80% of cases. Other causes include retained placenta, genital tract trauma, and coagulation disorders. Prevention strategies include active management of the third stage of labour and treatment involves restoring blood volume, ensuring uterine contraction, and potential surgical interventions if bleeding cannot be controlled. Without timely treatment, PPH can lead to complications like shock and death within a short period.
Postpartum hemorrhage is defined as bleeding more than 500ml following childbirth. It can be primary within 24 hours or secondary between 24 hours to 6 weeks. The main causes of primary PPH are uterine atony, retained placental tissue, lacerations, and coagulation disorders. Risk factors include overdistention of the uterus, previous PPH, prolonged labor, and preeclampsia. Clinical presentation includes heavy bleeding and signs of shock. Management involves bimanual compression, B-Lynch brace suture, exclusion of retained tissue, and antibiotic treatment for endometritis in secondary PPH cases.
Anaesthetic management of ruptured ectopic pregnancy by Arowojolu BoluwajiArowojolu Samuel
anaesthetic management of a patient with ruptured ectopic pregnancy. helping anaesthetist to know what to do in emergency anaesthesia. this is an emergency case. salpingectomy. arowojolu boluwaji
Postpartum hemorrhage (PPH) is defined as blood loss of more than 500 ml after vaginal delivery or 1000 ml after cesarean section. PPH accounts for 30% of all maternal deaths worldwide with over 500,000 deaths per year. The main causes of PPH are uterine atony (70%), trauma (20%), and tissue factors (10%). PPH can be prevented through active management of the third stage of labor. Initial management of atonic PPH involves uterine massage, uterotonic drugs, bimanual compression, and aortic compression. If bleeding continues, subsequent steps include uterine packing, B-Lynch suture, and hysterectomy as a last resort.
Postpartum haemorrhage remains a major cause of maternal mortality. Primary PPH occurs within 24 hours of delivery while secondary PPH occurs between 24 hours to 12 weeks postpartum. The main causes of PPH are uterine atony, retained placenta or clots, genital tract trauma, and coagulation disorders. Management involves early recognition, fluid resuscitation, medical treatment including uterotonics, surgical interventions if needed, and potentially hysterectomy for severe or uncontrolled bleeding. Prevention strategies focus on risk factor identification and active management of the third stage of labor.
Antepartum haemorrage by dr alka mukherjee AND dr apurva mukherjee nagpur m.s...alka mukherjee
A number of clinical and epidemiological studies have identified predisposing risk factors for placental abruption. The most predictive is abruption in a previous pregnancy. risk factors for placental abruption include: pre-eclampsia, fetal growth restriction, non-vertex presentations, polyhydramnios, advanced maternal age, multiparity, low body mass index (BMI), pregnancy following assisted reproductive techniques, intrauterine infection, premature rupture of membranes, abdominal trauma (both accidental and resulting from domestic violence), smoking and drug misuse (cocaine and amphetamines) during pregnancy. First trimester bleeding increases the risk of abruption later in the pregnancy
Maternal thrombophilias have been associated with placental abruption
Risk factors for placenta PRAVIA - Previous placenta praevia , Previous caesarean sections , Previous termination of pregnancy, Multiparity, Advanced maternal age (>40 years) , Multiple pregnancy Smoking Deficient endometrium due to presence or history of: • uterine scar • endometritis • manual removal of placenta • curettage • submucous fibroid Assisted conception
In view of the known associations between placental abruption and tobacco use, cocaine and amphetamine misuse, women should be advised and encouraged to modify these risk factors. No evidence was identified that specifically investigated smoking cessation and APH. A Cochrane review concluded that smoking cessation programmes in pregnancy reduce the proportion of women who continue to smoke, and reduce low birthweight and preterm birth. The pooled trials have inadequate power to detect reductions in perinatal mortality or very low birthweight and did not specifically analyse rates of APH. It is considered good practice to avoid vaginal and rectal examinations in women with placenta praevia, and to advise these women to avoid penetrative sexual intercourse.
Complications of APH Maternal complications Fetal complications Anaemia Fetal hypoxia Infection Small for gestational age and fetal growth restriction Maternal shock Prematurity (iatrogenic and spontaneous) Renal tubular necrosis Fetal death Consumptive coagulopathy Postpartum haemorrhage Prolonged hospital stay Psychological sequelae Complications of blood transfusion
1. Secondary postpartum hemorrhage (PPH) is defined as excessive or fresh bleeding from the vagina between 24 hours and 12 weeks after childbirth.
2. Causes of secondary PPH include retained placenta, infection, trauma, uterine abnormalities, and coagulation disorders.
3. Assessment involves vital signs, uterine size, cervical examination, and lab tests. Conservative management includes antibiotics, uterotonic drugs, and surgical intervention if bleeding continues.
4. For unstable patients, resuscitation is prioritized with IV fluids, blood products, and treating the underlying cause. Hysterectomy may be required in some severe cases.
This document discusses the diagnosis and management of two obstetric emergency cases. The first case involves a 26-year-old pregnant woman at 8 months gestation presenting with vaginal bleeding. This is diagnosed as antepartum haemorrhage, which can be caused by placental abruption or placenta previa. Ultrasound is used to differentiate between the two. The second case involves a woman who just gave birth with continuous bleeding. This is diagnosed as postpartum haemorrhage, which is most commonly caused by uterine atony. Management of both cases involves initial resuscitation, identifying the cause, controlling bleeding through medical or surgical methods such as uterotonic drugs, compression sutures,
Based on the results of two randomized controlled trials included in this meta-analysis that compared carbetocin to oxytocin for preventing postpartum hemorrhage, carbetocin was found to significantly reduce the need for additional uterotonic therapy compared to oxytocin, with a risk ratio of 0.44 (95% CI 0.25 to 0.78).
The document discusses management of postpartum haemorrhage (PPH). It outlines prevention through antenatal care, active management of the third stage of labor, and treatment through medical and surgical methods. Prevention focuses on risk identification and prophylactic oxytocics. Treatment begins with medical methods like uterotonic drugs and compression but may require procedures like uterine artery ligation, hysterectomy, or other surgeries to control bleeding if medical methods fail. Proper diagnosis, resuscitation, blood transfusion, and a multidisciplinary approach are essential to manage PPH.
Surgical management of pph at tertiary centerdrmcbansal
This document provides information on the surgical management of postpartum hemorrhage (PPH) at a tertiary care center. It discusses the definition, causes, incidence, and risk factors of PPH. The key points are:
1. PPH is a leading cause of maternal mortality worldwide, responsible for nearly 30% of maternal deaths in India. Delay in seeking or receiving care contributes to higher mortality.
2. The major causes of PPH are uterine atony (70% of cases), lacerations (20%), and retained placental tissue (10%). Morbidly adherent placentas like placenta accreta are also discussed.
3. Active management of the
Postpartum hemorrhage (PPH) is defined as blood loss greater than 500 mL following vaginal birth or 1000 mL following c-section. It can occur within 24 hours (primary PPH) or 24 hours to 12 weeks (secondary PPH) postpartum and is a leading cause of maternal mortality. The 4 T's of PPH include tonicity (uterine atony), tissue (retained placental fragments), trauma, and thrombin abnormalities. A case is presented of a woman with risk factors of preeclampsia and prolonged labor who develops PPH. Her management involves IV fluids, uterotonics, uterine massage, and monitoring for signs of deterioration requiring additional interventions like embolization
The use of algorithms & emergency boxes in obstetric emergencyWafaa Benjamin
1. Communicate the emergency and alert all necessary staff.
2. Resuscitate the patient with oxygen, IV fluids, and blood products to restore circulation and oxygen-carrying capacity.
3. Continuously monitor vital signs and investigate laboratory values every 15 minutes to guide resuscitation efforts. Stop the bleeding through techniques like bimanual compression, uterotonic drugs, balloon tamponade, or surgical interventions if needed.
1) The document discusses various causes of obstetric haemorrhage including placenta previa, placental abruption, uterine rupture, retained placenta, and uterine atony.
2) Management of antepartum bleeding depends on severity and may involve bed rest, tocolytics, magnesium sulfate, or caesarean section if bleeding is severe or fetus is mature.
3) Postpartum haemorrhage treatment includes bimanual compression, uterine massage, oxytocin, ergot alkaloids, or prostaglandins to manage uterine atony, the most common cause of postpartum haemorrhage.
1. Obstetric emergencies include antepartum and postpartum hemorrhage from conditions like placenta previa, placental abruption, and uterine rupture.
2. Placenta previa is when the placenta implants in the lower uterine segment, potentially blocking the cervix and causing painless bleeding late in pregnancy.
3. Anesthetic management for placenta previa and other hemorrhages involves ensuring large bore IV access, blood product availability, and invasive monitoring while determining the need for general or neuraxial anesthesia depending on maternal stability.
1. Antepartum haemorrhage (APH) refers to vaginal bleeding after 24 weeks of gestation and can endanger the lives of the mother and fetus. The most common causes are placenta previa and abruptio placentae.
2. Abruptio placentae involves premature separation of the placenta and can range from minor to major/life-threatening. General anaesthesia is recommended even in stable patients due to high risk of postpartum haemorrhage.
3. Placenta previa occurs when the placenta implants in the lower uterine segment, potentially causing painless bleeding. Grading depends on proximity to the cervical os. Spinal
This document discusses postpartum hemorrhage, including definition, risk factors, diagnosis, and treatment. It begins with two case examples of women experiencing heavy bleeding after delivery. The main causes of postpartum hemorrhage - uterine atony, retained placenta, lacerations, and coagulation disorders - are reviewed. Treatment focuses on the "four Ts": addressing tone with uterotonic drugs, checking for retained tissue, repairing any trauma, and evaluating for thrombin abnormalities. Early diagnosis and treatment are important to prevent severe bleeding and potential mortality from postpartum hemorrhage.
This document summarizes causes, risk factors, diagnosis, and management of postpartum hemorrhage (PPH). PPH is defined as blood loss of 500 ml or more within 24 hours of delivery. Common causes include uterine atony (70%), retained placenta, genital tract trauma, and bleeding disorders. Risk factors include previous uterine surgery, uterine abnormalities, and operative delivery. Diagnosis involves estimating blood loss and identifying the cause. Management involves resuscitation, arresting the bleeding through uterotonic drugs, manual removal of retained placenta, repairing lacerations, and in severe cases, surgical procedures like hysterectomy.
This document summarizes several obstetric emergencies, including classifications, approaches, and management strategies. Obstetric emergencies can be maternal or fetal and include hemorrhage, hypertension, uterine rupture, and cord prolapse. The structured ABC approach is recommended to initially assess and stabilize all emergency patients. Specific conditions like placenta previa require monitoring or delivery depending on bleeding and gestational age. Overall the document provides an overview of evaluating and treating common high-risk pregnancies and deliveries.
Postpartum haemorrhage (PPH) is the leading cause of maternal mortality worldwide, accounting for 25-50% of deaths. PPH is defined as blood loss of 500ml or more within 24 hours of delivery. Uterine atony is the most common cause, occurring in 80% of cases. Other causes include retained placenta, genital tract trauma, and coagulation disorders. Prevention strategies include active management of the third stage of labour and treatment involves restoring blood volume, ensuring uterine contraction, and potential surgical interventions if bleeding cannot be controlled. Without timely treatment, PPH can lead to complications like shock and death within a short period.
Postpartum hemorrhage is defined as bleeding more than 500ml following childbirth. It can be primary within 24 hours or secondary between 24 hours to 6 weeks. The main causes of primary PPH are uterine atony, retained placental tissue, lacerations, and coagulation disorders. Risk factors include overdistention of the uterus, previous PPH, prolonged labor, and preeclampsia. Clinical presentation includes heavy bleeding and signs of shock. Management involves bimanual compression, B-Lynch brace suture, exclusion of retained tissue, and antibiotic treatment for endometritis in secondary PPH cases.
Anaesthetic management of ruptured ectopic pregnancy by Arowojolu BoluwajiArowojolu Samuel
anaesthetic management of a patient with ruptured ectopic pregnancy. helping anaesthetist to know what to do in emergency anaesthesia. this is an emergency case. salpingectomy. arowojolu boluwaji
Postpartum hemorrhage (PPH) is defined as blood loss of more than 500 ml after vaginal delivery or 1000 ml after cesarean section. PPH accounts for 30% of all maternal deaths worldwide with over 500,000 deaths per year. The main causes of PPH are uterine atony (70%), trauma (20%), and tissue factors (10%). PPH can be prevented through active management of the third stage of labor. Initial management of atonic PPH involves uterine massage, uterotonic drugs, bimanual compression, and aortic compression. If bleeding continues, subsequent steps include uterine packing, B-Lynch suture, and hysterectomy as a last resort.
Postpartum haemorrhage remains a major cause of maternal mortality. Primary PPH occurs within 24 hours of delivery while secondary PPH occurs between 24 hours to 12 weeks postpartum. The main causes of PPH are uterine atony, retained placenta or clots, genital tract trauma, and coagulation disorders. Management involves early recognition, fluid resuscitation, medical treatment including uterotonics, surgical interventions if needed, and potentially hysterectomy for severe or uncontrolled bleeding. Prevention strategies focus on risk factor identification and active management of the third stage of labor.
Antepartum haemorrage by dr alka mukherjee AND dr apurva mukherjee nagpur m.s...alka mukherjee
A number of clinical and epidemiological studies have identified predisposing risk factors for placental abruption. The most predictive is abruption in a previous pregnancy. risk factors for placental abruption include: pre-eclampsia, fetal growth restriction, non-vertex presentations, polyhydramnios, advanced maternal age, multiparity, low body mass index (BMI), pregnancy following assisted reproductive techniques, intrauterine infection, premature rupture of membranes, abdominal trauma (both accidental and resulting from domestic violence), smoking and drug misuse (cocaine and amphetamines) during pregnancy. First trimester bleeding increases the risk of abruption later in the pregnancy
Maternal thrombophilias have been associated with placental abruption
Risk factors for placenta PRAVIA - Previous placenta praevia , Previous caesarean sections , Previous termination of pregnancy, Multiparity, Advanced maternal age (>40 years) , Multiple pregnancy Smoking Deficient endometrium due to presence or history of: • uterine scar • endometritis • manual removal of placenta • curettage • submucous fibroid Assisted conception
In view of the known associations between placental abruption and tobacco use, cocaine and amphetamine misuse, women should be advised and encouraged to modify these risk factors. No evidence was identified that specifically investigated smoking cessation and APH. A Cochrane review concluded that smoking cessation programmes in pregnancy reduce the proportion of women who continue to smoke, and reduce low birthweight and preterm birth. The pooled trials have inadequate power to detect reductions in perinatal mortality or very low birthweight and did not specifically analyse rates of APH. It is considered good practice to avoid vaginal and rectal examinations in women with placenta praevia, and to advise these women to avoid penetrative sexual intercourse.
Complications of APH Maternal complications Fetal complications Anaemia Fetal hypoxia Infection Small for gestational age and fetal growth restriction Maternal shock Prematurity (iatrogenic and spontaneous) Renal tubular necrosis Fetal death Consumptive coagulopathy Postpartum haemorrhage Prolonged hospital stay Psychological sequelae Complications of blood transfusion
1. Secondary postpartum hemorrhage (PPH) is defined as excessive or fresh bleeding from the vagina between 24 hours and 12 weeks after childbirth.
2. Causes of secondary PPH include retained placenta, infection, trauma, uterine abnormalities, and coagulation disorders.
3. Assessment involves vital signs, uterine size, cervical examination, and lab tests. Conservative management includes antibiotics, uterotonic drugs, and surgical intervention if bleeding continues.
4. For unstable patients, resuscitation is prioritized with IV fluids, blood products, and treating the underlying cause. Hysterectomy may be required in some severe cases.
This document discusses the diagnosis and management of two obstetric emergency cases. The first case involves a 26-year-old pregnant woman at 8 months gestation presenting with vaginal bleeding. This is diagnosed as antepartum haemorrhage, which can be caused by placental abruption or placenta previa. Ultrasound is used to differentiate between the two. The second case involves a woman who just gave birth with continuous bleeding. This is diagnosed as postpartum haemorrhage, which is most commonly caused by uterine atony. Management of both cases involves initial resuscitation, identifying the cause, controlling bleeding through medical or surgical methods such as uterotonic drugs, compression sutures,
Based on the results of two randomized controlled trials included in this meta-analysis that compared carbetocin to oxytocin for preventing postpartum hemorrhage, carbetocin was found to significantly reduce the need for additional uterotonic therapy compared to oxytocin, with a risk ratio of 0.44 (95% CI 0.25 to 0.78).
The document discusses management of postpartum haemorrhage (PPH). It outlines prevention through antenatal care, active management of the third stage of labor, and treatment through medical and surgical methods. Prevention focuses on risk identification and prophylactic oxytocics. Treatment begins with medical methods like uterotonic drugs and compression but may require procedures like uterine artery ligation, hysterectomy, or other surgeries to control bleeding if medical methods fail. Proper diagnosis, resuscitation, blood transfusion, and a multidisciplinary approach are essential to manage PPH.
Surgical management of pph at tertiary centerdrmcbansal
This document provides information on the surgical management of postpartum hemorrhage (PPH) at a tertiary care center. It discusses the definition, causes, incidence, and risk factors of PPH. The key points are:
1. PPH is a leading cause of maternal mortality worldwide, responsible for nearly 30% of maternal deaths in India. Delay in seeking or receiving care contributes to higher mortality.
2. The major causes of PPH are uterine atony (70% of cases), lacerations (20%), and retained placental tissue (10%). Morbidly adherent placentas like placenta accreta are also discussed.
3. Active management of the
Postpartum hemorrhage (PPH) is defined as blood loss greater than 500 mL following vaginal birth or 1000 mL following c-section. It can occur within 24 hours (primary PPH) or 24 hours to 12 weeks (secondary PPH) postpartum and is a leading cause of maternal mortality. The 4 T's of PPH include tonicity (uterine atony), tissue (retained placental fragments), trauma, and thrombin abnormalities. A case is presented of a woman with risk factors of preeclampsia and prolonged labor who develops PPH. Her management involves IV fluids, uterotonics, uterine massage, and monitoring for signs of deterioration requiring additional interventions like embolization
The use of algorithms & emergency boxes in obstetric emergencyWafaa Benjamin
1. Communicate the emergency and alert all necessary staff.
2. Resuscitate the patient with oxygen, IV fluids, and blood products to restore circulation and oxygen-carrying capacity.
3. Continuously monitor vital signs and investigate laboratory values every 15 minutes to guide resuscitation efforts. Stop the bleeding through techniques like bimanual compression, uterotonic drugs, balloon tamponade, or surgical interventions if needed.
1) The document discusses various causes of obstetric haemorrhage including placenta previa, placental abruption, uterine rupture, retained placenta, and uterine atony.
2) Management of antepartum bleeding depends on severity and may involve bed rest, tocolytics, magnesium sulfate, or caesarean section if bleeding is severe or fetus is mature.
3) Postpartum haemorrhage treatment includes bimanual compression, uterine massage, oxytocin, ergot alkaloids, or prostaglandins to manage uterine atony, the most common cause of postpartum haemorrhage.
Transfusion involves preparing and transfusing blood and blood products. It involves whole blood, packed red blood cells, plasma, platelets, and plasma fractions. Major causes of maternal morbidity and mortality are chronic anemia of pregnancy and major obstetric hemorrhage. For hemorrhage, initial resuscitation with fluids is priority to restore volume, followed by packed red blood cells and component replacement based on coagulation tests. Continuous monitoring guides treatment, and identifying/treating the cause of bleeding is important. Risks of transfusion include febrile reactions, infections, and complications from stored blood.
-maschera laringea
-laringoscopio
-fibroscopio
-kit per cannule di Guedel
-kit per cannule di Bougie
-kit per intubazione difficile
Servizio di Anestesia e Rianimazione Ospedale di Faenza(RA)
Preparazione del carrello
Servizio di Anestesia e Rianimazione Ospedale di Faenza(RA)
Preparazione del carrello
Servizio di Anestesia e Rianimazione Ospedale di Faenza(RA)
Preparazione del carrello
This document summarizes several common obstetric emergencies and their anesthetic management. It discusses hemorrhage from placenta previa, placental abruption, placenta accreta, and postpartum causes. It also reviews uterine rupture, retained placenta, and uterine atony. For each condition, it describes signs, treatment, and considerations for anesthesia including fluid resuscitation and choice of regional versus general anesthesia based on the clinical situation. The document provides an overview of classification of hemorrhagic shock and approaches to fluid resuscitation.
BLOOD & BLOOD COMPONENTS IN OBSTETRICS BY DR SHASHWAT JANIDR SHASHWAT JANI
This document provides information from Dr. Shashwat Jani regarding obstetric hemorrhage and blood transfusion. It discusses the main causes of maternal morbidity and mortality as chronic anemia and major obstetric hemorrhage. It then outlines reasons why mothers die due to hemorrhage, including inadequate resources, failure to prepare, delays in recognition and treatment, and unavailable expertise. The document also summarizes different blood products that can be used for transfusion including packed red cells, fresh frozen plasma, platelets, and cryoprecipitate. It provides indications, dosing, and guidelines for use of each component.
Postpartum haemorrhage (PPH) is a major cause of maternal mortality. It can be primary (within 24 hours of delivery) or secondary (24 hours to 6 weeks postpartum). Primary PPH is usually due to uterine atony or trauma during delivery. Management involves emptying the uterus, replacing blood loss, and ensuring haemostasis. Secondary PPH is often caused by infection or retained placental fragments. Treatment focuses on identifying and addressing the underlying cause while providing supportive care.
The document summarizes various techniques for retrieving sperm from men with azoospermia for use in IVF-ICSI procedures. It discusses the differences between obstructive and non-obstructive azoospermia and various sperm retrieval methods such as MESA, TESE, and microdissection TESE. It also covers evidence for techniques like FNA mapping followed by directed TESE to potentially improve sperm retrieval rates in men with non-obstructive azoospermia.
Spinal anesthesia involves injecting local anesthetic into the subarachnoid space to temporarily numb sensation and motor function in the lower body. The anesthesiologist inserts the needle below L2 to access the spinal fluid and avoid the spinal cord. Spinal anesthesia provides excellent surgical conditions for various abdominal, pelvic, and lower extremity procedures. It has been used since the late 1800s and involves carefully positioning the patient and needle to safely access the spinal fluid and distribute the anesthetic in the spinal canal.
The document discusses obstetric emergencies including massive obstetric hemorrhage, antepartum hemorrhage from placenta previa or abruption, uterine rupture, and postpartum hemorrhage. It provides definitions, risk factors, diagnostic criteria, management guidelines, and anesthetic considerations for each of these conditions. Prevention and treatment involve careful monitoring, IV access, blood products, oxytocic medications, and timely delivery when indicated to stabilize both mother and fetus.
- Decompression of the abdominal compartment by
opening the abdomen and leaving it open with a
temporary abdominal closure device.
- Aggressive fluid resuscitation should be avoided to prevent dilutional coagulopathy and increased intra-abdominal pressures. Early administration of platelets and fresh frozen plasma in a 1:1:1 ratio with packed red blood cells can help achieve hemostasis earlier.
- Cesarean hysterectomy is usually required for placenta accreta, though in select stable cases a conservative approach retaining the placenta may be attempted with strict follow up given high morbidity.
Postpartum hemorrhage is defined as blood loss exceeding 500 mL after vaginal delivery or 1000 mL after cesarean delivery within 24 hours. It occurs in 4% of deliveries and is primarily caused by uterine atony, genital tract trauma, retained placental tissue, and coagulation disorders. Management involves identifying the cause, such as through manual exploration of the uterus, repairing lacerations, administering uterotonic drugs to contract the uterus, and treating underlying coagulation disorders. Surgical interventions like hysterectomy may be needed for severe cases unresponsive to initial treatment measures.
This document discusses obstetric analgesia and anesthesia techniques. It covers:
1) Characteristics of drugs used including local anesthetics, their mechanisms of action, and placental transfer.
2) Techniques for regional analgesia including local infiltration, epidural, spinal and their combinations. Systemic analgesics are also discussed.
3) Considerations for analgesia and anesthesia in abnormal obstetrics like fetal distress, preeclampsia, hemorrhage. Safety of mother and fetus is the primary concern.
Blood Transfusion in Obstetrics Green-top Guideline 2015Aboubakr Elnashar
This document provides guidelines for blood transfusion in obstetrics. It discusses reducing the risks of transfusion, general transfusion principles, strategies to minimize banked blood use, management of obstetric hemorrhage with blood components, pharmacological strategies, and management of intrapartum, postpartum anemia and women who decline blood products. The guidelines recommend optimizing hemoglobin, using cell salvage and restrictive transfusion protocols to reduce banked blood use, and considering tranexamic acid and fibrinogen concentrate for major hemorrhage. Clinicians should have clear protocols for hemorrhage management and intrapartum anemia transfusion criteria.
This document provides information on spinal anesthesia techniques. It begins with a brief history of spinal anesthesia dating back to 1885. It then covers topics such as indications, contraindications, preoperative evaluation, techniques, complications and their management. Specific details are provided on patient positioning, identifying anatomical landmarks, different needle approaches, administering anesthetic solutions and factors affecting spinal block height. The document aims to guide practitioners on safe and effective spinal anesthesia procedures.
Dr. John Snow popularized the use of pain relief during labor when he administered chloroform to Queen Victoria for the birth of her eighth child. The document discusses various methods of pain relief during labor, including non-pharmacological methods like Lamaze breathing techniques, and pharmacological methods like opioids administered parenterally or via neuraxial routes. It also addresses maternal and fetal risks, goals of labor analgesia, and the roles of obstetricians and anesthesiologists in managing labor pain.
The document discusses placenta accreta, a condition where the placenta invades and attaches abnormally to the uterine wall. It has increased in incidence 10-fold over the past 50 years due to rising cesarean delivery rates. Risk factors include placenta previa, prior uterine surgery, and increasing maternal age and parity. Ultrasound and MRI can be used to diagnose placenta accreta prenatally based on signs like lack of a hypoechoic zone between the placenta and uterus. Management options for severe postpartum hemorrhage from placenta accreta include uterine packing, arterial ligation, hysterectomy, and the B-Lynch compression suture
The Jada System is a new device for treating postpartum hemorrhage (PPH). A clinical study of 107 women found that the Jada System was 94% effective in controlling PPH within 3 minutes of use, without need for further intervention. The study also found a very low rate of device-related adverse events, demonstrating the Jada System's excellent safety profile. Investigators reported that the Jada System was easy to use, with 98% finding it simple to insert and remove. The study provides strong evidence that the Jada System is a fast, definitive, and physiologic option for resolving PPH in a safe and effective manner.
This document provides information on various topics related to obstetrics and gynecology:
- Risks and outcomes associated with different gestational ages, labor interventions, and deliveries.
- Predictors and management of preterm labor, postpartum hemorrhage, breech presentation, and other high-risk pregnancies.
- Details on twin pregnancies, screening tests for fetal abnormalities, and caesarean section risks.
- Risks of various gynecological procedures like laparoscopy, hysteroscopy, and hysterectomy.
- Causes and management of infertility, endometriosis, fibroids, and heavy menstrual bleeding.
- Details on contraception
This document discusses massive obstetric hemorrhage (MOH), including its definition, causes, incidence, impact on maternal health, clinical presentation, management, and prognosis. Some key points:
- MOH is a leading cause of maternal death worldwide and in sub-Saharan Africa. It is defined as blood loss greater than 1500ml or a decrease in hemoglobin of more than 4g/dl.
- Common causes of MOH include uterine atony, genital tract trauma, and retained placenta. Early diagnosis and treatment with uterotonics, fluid resuscitation, blood transfusions, and potential interventions like hysterectomy can help manage MOH.
- Outcomes are better when treatment
Primary postpartum hemorrhage is a leading cause of maternal mortality. This presentation defines PPH as blood loss exceeding 500mL after vaginal delivery or 1000mL after c-section within 24 hours of delivery. The main causes are uterine atony, retained placenta or clots, genital tract trauma, and coagulopathy. Risk factors include previous c-sections, multiple gestation, and medical disorders. Prevention focuses on active management of the third stage of labor and treatment involves addressing the underlying cause, fluid resuscitation, blood transfusion, and potentially hysterectomy for uncontrolled bleeding.
APH affects 3-5% of pregnancies and is a leading cause of preterm birth. Clinical assessment of APH involves history, examination, and ultrasound to determine the cause and severity of bleeding and risk to the mother and fetus. Management priorities are resuscitation of the mother, monitoring the fetus, restricting activity and delivery depending on gestational age and severity of the condition.
Postpartum haemorrhage (PPH) is defined as excessive bleeding after childbirth. It can occur within the first 24 hours (primary PPH) or between 24 hours and 12 weeks (secondary PPH). PPH is a leading cause of maternal mortality. Risk factors include previous PPH, multiple pregnancy, and prolonged labour. Prevention through optimal health and identifying risks is important. Management involves assessing blood loss, stopping bleeding, resuscitation, and fluid replacement.
This slide presents some Gynecologic diseases and disorders in females and their proper management. It is a third-year course for those wishing to major PA or Nursing.
This study evaluates the use of inverting the cervix as a natural tamponade to control bleeding in cases of placenta previa and accreta. The study included 35 patients who underwent cesarean section where the cervix was inverted and sutured over the placental bed. This technique successfully controlled bleeding in 33 of 35 patients (94%). Only 2 patients required a hysterectomy. The mean blood loss was 1572.5 mL. At 3 month follow up, most cervices (29/31) appeared normal on speculum exam. This simple technique utilizes the cervix as a natural tamponade and appears to be an effective way to control bleeding and preserve the uterus in cases of placenta
This document discusses miscarriage, ectopic pregnancy, and recurrent miscarriage. It defines miscarriage as pregnancy loss before 24 weeks and notes the most common sign is vaginal bleeding. For ectopic pregnancy, it describes the risk factors, symptoms, and treatments which include expectant management, medical treatment with methotrexate, or surgical treatment. Recurrent miscarriage is defined as 3 or more consecutive losses and investigations and treatments are discussed including aspirin, heparin, surgery for anatomical issues, and psychological support.
This document discusses early pregnancy bleeding and differentials, implantation in early pregnancy, ultrasound findings, miscarriage definitions and management options, ectopic pregnancy risk factors and treatments, and recurrent miscarriage evaluation. It defines miscarriage as loss of intrauterine pregnancy before 24 weeks and describes expectant, medical, and surgical management options. For ectopic pregnancies, it notes fallopian tubes as the most common site and lists risk factors. Treatment may involve methotrexate or laparoscopic salpingectomy.
This document discusses women's health issues related to thrombosis. It notes that pregnancy carries a significantly increased risk of venous thromboembolism (VTE) compared to non-pregnant women. Diagnosis of VTE can be challenging during pregnancy due to modified diagnostic tests and interpretation. Treatment typically involves therapeutic doses of low molecular weight heparin throughout pregnancy and postpartum. Women with antiphospholipid syndrome face additional risks and may benefit from prophylactic heparin and low-dose aspirin. Hormone-based contraceptives and hormone replacement therapy can also impact coagulation factors and VTE risk.
This document discusses trauma during pregnancy, including:
1) Trauma affects 1 in 12 pregnancies and is a leading cause of nonobstetric death, though 90% of injuries are minor.
2) Special considerations in the assessment and management of pregnant trauma patients include changes in cardiovascular, respiratory, gastrointestinal/genitourinary systems as well as injury patterns.
3) The goals in treating pregnant trauma patients are to first stabilize the mother to save the fetus, as maternal demise will lead to fetal demise in most cases. A multidisciplinary approach between trauma and obstetrics teams is important.
This document discusses causes and management of antepartum haemorrhage (APH). The main causes are placenta praevia (20%), abruptio placentae (30%), and indeterminate (45%). Management involves resuscitation, identifying the cause using ultrasound, and managing the specific cause. Placenta praevia risks include prematurity and PPH. Abruptio placentae risks include fetal death from inadequate oxygen. Women with prior c-sections are at increased risk of morbidly adherent placenta. Indeterminate APH requires delivery by 40 weeks due to possible minor abruptio.
ECTOPIC PREGNANCY - FOGSI GUIDELINES BY DR SHASHWAT JANIDR SHASHWAT JANI
Ectopic pregnancy occurs when a fertilized egg implants outside the uterus, usually in the fallopian tubes. It poses a significant health risk and is a leading cause of maternal death early in pregnancy. The document discusses the diagnosis, risk factors, clinical presentation, treatment options including expectant management, medical management with methotrexate, and surgical management via laparoscopy or laparotomy for ectopic pregnancy. The aim of treatment is to preserve the health and future fertility of the woman.
An ectopic pregnancy occurs when a fertilized egg implants somewhere other than the uterus, usually in the fallopian tubes. Ectopic pregnancies account for 2% of pregnancies and are the leading cause of maternal death in early pregnancy. Symptoms include missed period, abdominal pain, and vaginal bleeding. Diagnosis is confirmed through blood tests of human chorionic gonadotropin and progesterone levels and transvaginal ultrasound. Treatment depends on the stability of the patient and may involve medication with methotrexate or surgery either laparoscopically or through laparotomy. Prompt diagnosis and treatment are important to prevent life-threatening complications.
Hemorrhage remains a leading cause of maternal mortality. This document discusses various causes of antepartum and postpartum hemorrhage, including placenta previa, placental abruption, uterine rupture, and coagulation disorders. It provides details on risk factors, symptoms, diagnosis, and management for each condition. Prevention and early recognition are key to minimizing the impact of postpartum hemorrhage.
The document provides an overview of postpartum hemorrhage (PPH) including its definition, risk factors, causes, prevention, and management. It discusses predicting patients at risk, preparing for potential hemorrhage, and treating PPH through evaluating tone, tissue, trauma, and thrombin (the 4 Ts). Uterine atony is identified as the leading cause, accounting for 80% of PPH cases. Early use of uterotonic medications and fluid resuscitation are emphasized as essential in management.
Motor vehicle accidents, falls, and assaults are the most common causes of trauma during pregnancy. Proper seatbelt positioning is important for safety. The primary survey focuses on stabilizing the mother first before assessing the fetus. Abruption is the leading cause of fetal loss from minor trauma, so fetal monitoring is crucial. For major trauma, the same approach as a non-pregnant patient is followed except positioning the mother on her left side. Perimortem c-section should deliver the baby within 5 minutes of maternal cardiac arrest.
Vaginal bleeding in late pregnancy, known as antepartum hemorrhage, can be caused by placenta previa, abruptio placentae, or other rare conditions. Placenta previa, where the placenta covers all or part of the cervix, accounts for 20% of antepartum hemorrhage cases and is diagnosed using ultrasound. Abruptio placentae is the premature separation of a normally implanted placenta and can result in fetal death in 1 in 500 deliveries. The management of placenta previa and abruptio placentae involves stabilizing the patient and either expectant management or delivery depending on gestational age and maternal/fetal stability
Pregnancy increases the risk of venous thromboembolism (VTE) due to physiological changes that cause a hypercoagulable state. The risk is highest in the first trimester and up to 6 weeks postpartum, and further increased with caesarean sections. VTE is a leading cause of maternal death in the UK. Risk factors include previous VTE, thrombophilia, immobility, and obesity. Thromboprophylaxis is recommended for high risk women. Diagnosis involves Doppler ultrasound or CT scan, and treatment involves low molecular weight heparin for 6 months. Amniotic fluid embolism and air embolism are rare but life-threatening complications of pregnancy
This document summarizes the training process for anesthesiologists in the United States. It outlines the educational requirements including undergraduate studies, medical school, residency training, and licensing exams. Residency training typically lasts 4 years and involves rotations in different specialties like pediatrics, cardiac, and neurosurgery. The training emphasizes patient safety, duty hour limits, and developing skills in perioperative care, acute and chronic pain management, and crisis situations. Overall, the training produces physicians skilled in integrated medical management and efficient, cost-effective surgical care for patients.
This document summarizes changes to general anesthesia techniques for Caesarean sections over recent decades. It discusses replacing the old "thiopentone-suxamethonium" rapid sequence induction with newer options like ketamine-propofol or rocuronium paired with sugammadex reversal. Modifications have been made to pre-oxygenation, induction agents, neuromuscular blockade, inhalational agents, adjuncts, and emphasis on meticulous timing. The "Gatt Rule of 100s" proposes a standardized induction sequence with rocuronium reversal by sugammadex within 100 seconds of delivery. Overall, it examines how the traditional general anesthesia Caesarean section technique evolved due to
This document discusses diabetes and pregnancy, focusing on gestational diabetes (GDM). It provides information on:
1) The pathophysiology and risk factors of GDM, noting that it is characterized by increased insulin resistance and inadequate insulin secretion as pregnancy progresses.
2) Findings from the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study that showed associations between higher maternal glucose levels and increased risk of adverse pregnancy outcomes.
3) International recommendations and criteria for screening and diagnosing GDM, which vary between organizations like ADA, IADPSG, and WHO. Regular screening is recommended between 24-28 weeks gestation.
This document discusses peripartum seizures and provides several case studies. It outlines an algorithmic approach for evaluating and managing peripartum seizures. Causes can include preeclampsia, eclampsia, epilepsy, or other neurological conditions. Initial treatment involves magnesium sulfate, controlling blood pressure and monitoring. Atypical presentations require further investigation like imaging to rule out conditions like cerebral venous sinus thrombosis. MRI is generally preferred over CT for imaging during pregnancy due to risks of radiation and better detection of conditions like posterior reversible encephalopathy syndrome. Management after delivery includes continued magnesium sulfate, antihypertensives, anticonvulsants and thromboprophylaxis as needed.
This document discusses the management of high risk parturients, or pregnant women with medical complications or risk factors. It defines high risk parturients and outlines common medical conditions and obstetric risks that classify women as high risk. The document discusses strategies for assessing risk, creating individualized obstetric and anesthesia plans, and ensuring appropriate care for high risk women during labor, delivery and emergencies. It emphasizes the importance of a multidisciplinary team approach, systems to facilitate safe handovers of care, and the need for regional high risk obstetric databases and audits to continually improve care for this patient population.
The document discusses regional anesthesia techniques for caesarean section. It recommends using hyperbaric bupivacaine with fentanyl for spinal anesthesia. It suggests crystalloid cohydration for intravenous fluids and using phenylephrine instead of ephedrine as the vasopressor. The document also recommends combined spinal-epidural anesthesia to reduce spinal doses and improve hemodynamic stability. It provides guidance on epidural top-ups or converting to spinal anesthesia if the epidural fails. The key points emphasize optimal drug choices, fluid management, hemodynamic control and contingency plans for regional anesthesia during caesarean sections.
A 34-year-old Vietnamese woman presented with pulmonary thromboembolism following a cesarean delivery. She experienced cardiac arrest and was resuscitated, but later died from a pulmonary embolism. Pregnancy increases the risks of deep vein thrombosis and pulmonary embolism due to venous stasis, a hypercoagulable state, and vascular injury during delivery. Cesarean delivery further increases these risks compared to vaginal birth. While low molecular weight heparin can effectively prevent and treat thrombosis, early recognition and treatment are needed to reduce the high mortality rates associated with pulmonary embolism during pregnancy.
This document discusses maternal mortality and complications related to obstetric anesthesia. It summarizes that a study of over 257,000 births found serious anesthesia complications in 85 patients (1 in 3,000), with high neuraxial block, respiratory arrest, and unrecognized spinal catheter being the most common. It also provides background information on maternal mortality rates in the Philippines.
Ropivacaine is a new local anesthetic with less cardiovascular and neurological toxicity compared to bupivacaine. This study evaluated the effectiveness of spinal anesthesia using 14 mg of ropivacaine with 30 μg of fentanyl for total abdominal hysterectomies. Results showed that ropivacaine provided effective sensory blockade and muscle relaxation for surgery. Side effects like hypotension and nausea were mild and managed easily. Ropivacaine is concluded to be suitable for short gynecological surgeries allowing for early patient recovery and mobilization.
3. Obstetric haemorrhage, the first cause
of death and maternal complications
In Vietnam: 67.4% of all maternal deaths
In French:
= 30% of deaths from direct obstetric causes = 10 deaths / year
Maternal complication rate = 6.7 / 1000 births (6.0 to 7.5): shock
bleeding, severe anemia, complications of large volume blood
transfusions, kidney, pituitary necrosis.
Around the world:
140,000 deaths / year every 4 minutes with a maternal mortality.
Half of these deaths occur 24 hours after birth
4. Obstetric haemorrhage
The leading cause of direct maternal death (%)
20
15
10
5
0
UK France
1988-1990 1991-1993 1997-1999
Statistics on maternal mortality in the UK
Statistics from the National Advisory Council on Maternal mortality France
5. Maternal deaths could be avoided
Causes of maternal deaths N
Tử vong mẹ có thể tránh khỏi
Yes May be % evitable No Conclusion inevitable
Due to direct obstetric
causes
92 30 12 51,6 26 19
hemorragie 30 15 4 73,3 3 5
Amniotic fluid embolism 10 0 0 0,0 9 1
Hypertention 16 4 3 43,7 4 5
MTE ? 14 2 3 35,7 7 2
Infection 7 3 2 71,4 2 0
Obstetric complications 5 3 1 80,0 0 1
Anesthesia complications 1 0 1 100,0 0 0
Another causes 9 2 1 37,5 1 5
Due to indirect obstetric
49 6 8 28,6 28 7
causes
Total causes 141 35 25 43,6 54 26
Statistics from the National Advisory Council on Maternal mortality France
6. Definition
• Physiological blood loss
- Vaginal delivery <500 ml
- C-section: 500 - 1000 ml
• Haemorrhage
- When normal delivery: 500 - 1000 ml
- In cesarean section:> 1000 mL
- Severe haemorrhage > 1500 mL
8. Cause of obstetric haemorrhage
according Lariboisier
Uterine
atony
Genital
trauma
Retained
placenta
Anormal
placenta Trombus Placental
abruption
Another
causes
9. The cause bleeding after birth in National hospital of OG
Total Percentage %
Group Causes
Atonie
Uterine atony 59 22,5
Retained placenta 18 6,9
Vaginal trauma
Genital trauma 33 12,6
perineal hematoma 4 1,5
Placenta
Placenta previa 51 19,5
Placenta abruption 12 4,6
Placenta accreta 15 5,7
Placenta increta 4 1,5
Complication of
cesarean
section
Vaginal trauma 10 3,8
Hematome abdominal 5 1,9
infection 11 4,2
Postpartum bleeding at the National Hospital of OG at 2008-2009 (Thesis, Bach Thi Cuc, HMU)
10. Factors related to postpartum bleeding and vaginal
delivery
Case-control study (USA)
9598 vaginal delivery
374 postpartum bleeding
(= 3.9%)
Risk Factors
Factors OR
Prolonged labor 7,56
preeclampsia 5,02
Episiotomy 4,67
History of obstetric
3,55
haemorrhage
multiple pregnancy 3,31
Labor induction 2,91
Soft tissue injury 2,05
Forceps 1,66
race 1,58-1,73
first pregnancy 1,45
Epidural anesthesia 1,00
Hight risks
Normal risks
Combs CA et al. Obstet Gynecol 1991;77:69-76
11. Factors related to bleeding and cesarean section
Case-control study (USA)
3052 cesarean section
196 bleeding (= 6.4%)
Risk Factors
Factors OR
General anesthesia 2,94
Chorioamnionitis 2,69
Preeclampsia 2,18
Labor dirigee prolongee 2,40
Cervical not progress 1,90
Race 1,58-1,73
Epidural anesthesia 1,00
Hight risks
Normal risks
Combs CA et al. Obstet Gynecol 1991;77:69-76
12. May prevent obstetric haemorrhage?
The risk factors for antenatal period
Age of women
Race
Marital status
Living standards and education levels
No follow-up pregnancy
Multiple pregnancy
Preeclampsia
Uterus had a previous caesarean scar +++
Placenta previa +++
Caesarean section
History of bleeding
Prehistoric yourself or a history of high-risk obstetric
Did not find any risk factor in
50% of cases
13. Abnormal placental
Location
• Placenta implants in low grip
• Placenta previa
The level of adherent placenta
• Placenta accreta
• Placenta increta
• Placenta percreta
15
10
5
0
Deaths
1985-1887 1988-1990 1991-1993
Postpartum hemorrhage
Placenta previa
placenta abruption
Statistics from the National Advisory Council on
Maternal mortality France
14. Uterine incision and anormal placenta
10
8
6
4
2
0
Số lần mổ đẻ trước đó
0 1 2 3 > 3
accreta
100
80
60
40
20
0
Số lần mổ đẻ trước đó
0 1 2 3 > 3
praevia + accreta
Clark SL et al. Obstet Gynecol 1985;66:89-
Time of cesarean
section in hystory
Time of cesarean
section in hystory
Time of cesarean section in
hystory
15. Placenta previa
The proportion of Placenta accreta / placenta previa:
3.7% by Xa Thi Minh Hoa, Hanoi Hospital of OG in 2012
5.4% by Le Thi Huong Tra, National Hospital of OG in 2007-2011
16. Placenta accreta
Abnormally adherent placenta
• Scale: 1/2000 - 1/7000 births
• Classify
- Placenta accreta vera: adherence to the myometrium without
invasion of uterine muscle
- Placenta increta: invasion uterine muscle.
- Placenta percreta: invasion of the uterine serosa or other pelvic
structures
• Risk: a fulminant bleeding in surgery, can be life-threatening
17. Placenta acreta
Research on the periode of 2007-2011, Placenta accreta in the
National Hospital of Obstetric and Gynecology
•100 cases
•60% had a history of cesarean section
•83% had placenta previa
•76% hysterectomy, ligation uterus artery 25%, 3% Blynch suture
•57% had a blood transfusion, in which 35% transmission> 5 units of
packed red blood cells (1 case 9 units of packed red blood cells )
(Le Thi Huong Tra, thesis of master, HMU, 2012)
18. Placenta acreta
Report 8 cases of Placenta percreta bladder in Central hospital of Hue
•7 patients require blood transfusion (87.5%)
•2 patients transfusion 5800 ml and 7500 ml of red blood cells
•100% total hysterectomy
(Bach Cam An)
Reported 1 case of Placenta accreta in patient had 2 times cesarean
section at Tu Du Hospital
•Operation time of 200 minutes, mobilizing 20 people
•6500 ml blood loss
•26 units of packed red blood cells, 12 Plasma, 16 Cryo, 1 packed of
platelete
(Ma Thanh Tung)
19. Placenta acreta
Attention of anesthesia
• Common in women with placenta previa, multiple previous caesarean
• Color Doppler diagnosis: sensitivity 96.8%, specificity 87.5% (Tran
Danh Cuong)
• Scheduled surgery plans
• 2 large intravenous lines, invasive blood pressure
• General anesthesia
• Packed red blood cells (PRBC)availability expected, plasma, Cryo,
platelete
• 2 units of PRBC available in the operating room before incision
• Request obstetrician clamp and cut the uterus immediately after
delivery
24. Haemorrhage post delivery
• 30-50% of cases do not see a clear risk factors (to
think of amniotic fluid embolism)
• Well tolerated in terms of hemodynamic, can not
change the loss of 1,500 ml of blood
• There coagulopathy in 50% of cases
• Incorrect or lately management caused 70%
mortality
25. Haemorrhage post delivery
Treatment
- Alert obstetrician and midwife
- Examination of uterus
• Removal and inspection of the placenta
• Currettage and surgical repair
• Evaluation of circulating volume
• Antibiotics
27. Medical uterotonic therapy
• Uterine massage
• These drugs increase the contraction of uterus
• * Oxytocin: Do not exceed 30 UI
• * Sulproston (Nalador): 30 minutes
• - Initial doses of 500 mcg for 1 hour, then 500 mcg / 6
hours
• - CI: asthma, coronary, severe hypertension
• - How to use: dilution 50 ml, perfusion 10 ml / hour. Add
10 ml / hr every 10 minutes for up to 50 ml / hour
• Maintenance dose of 10 ml / h for 6 hours
28. 101 women with normal pregnancies
Measuring the pressure in the chamber TC TC contraction taking 3 different medications
0 15 30 45 60 120 min
sulprostone
oxytocin
placebo
Baumgarten K et al. Eur J Obstet Gynecol 1983;16:181-92
%
methylergometrine
Onset of
efficacity sulpr. >
methylerg. ou
oxytocine.
Time methylerg. >
sulpr. >
oxytocine.
The pressure intra - uterus
29. Early drug use Nalador®
100
90
80
70
60
50
40
30
20
10
0
Treatment failure Treatment efficace
> 30 mn
< 30 mn
%
OR=8,3 ; IC à 95% : 2,2-31,7
Goffinet F. J Gynecol Obstet Biol Reprod 1995 ; 24 : 209-16
30. Management of severe postpartum bleeding
by PGF2
Hayashi RH, Obs Gyn 1984
• 18 000 births in 3 years
• 900 cases of postpartum bleeding
• 54 cases uterine atony with oxytocin and treated with
PGF2a
- Success: 86%
- Fever: 6%
- Sides effects on the digestive system: 9%
31. Why mothers die 1997-1999
Spinal anesthesia for caesarean section - direct intravenous oxytocin 5 UI
32. Blood transfusion
• Rarely, <1% of all births
• The risk of immune complications
secondary to blood transfusion:
need to prepare for future pregnancies
Research across France in 2003: 4% of the
scientific production time for a transfusion
of> 30 minutes
33. Control of blood transfusion
• Set the 2 line large diameter peripheral vein
• Try FBC
Bilan fluid and blood
Surveillance hémoglobin
Test hemoglobin, use the HemoCue ou Radical 7 Masimo
Coagulation test
Labo, Vitro test dry, TEG
2 dry test tubes: Tubes 1/3 blood volume in each tube
Tube 1: Tilt the tube every minute / time
When blood clot tube = recorded clotting time of tube 1
How well do the 2nd tube.
Then add the clotting time of 2 tubes back
- Normal <7 minutes
- Sure, coagulopathy when> 20 min
36. Reanimation
• Antithrombin III và Aprotinin
• Fibrinogen
• Role of Transamin
• Activated factor VII
(Novo seven - FVII exogene)
37. Disseminated intravascular coagulation (CIVD): Specific treatment
Antithrombine in CIVD heamorrage
During labor and birth
• Evaluation
• Number of units of plasma transfusion (PFC)
• Percentage of AT> 70%
Result
• clinical condition improved
• XN (TC number and percentage of prothrombin (TP)
increased significantly since firt day
• But the efficiency is very low
• Mortality rates did not differ between the 2 groups
Maki M. Gyn Obst Invest 1987
38. Reduce the number Fibrinogen is a marker for early
severity of postpartum bleeding
Fibrinogen concentration index is the only independent
related to the progression of postpartum bleeding
Prognostic value of these results focus between
The first hour to hour 4
39. Anti-fibrinolytic
•Randomized multicenter
• Measure the volume of blood loss during and after cesarean
• 180 nulliparous women with no risk factors
• Tranexamique acid injection before incision:
•1g then transmit 3 g / 3 hours
• 20% reduction in bleeding in the period from
• when taken during pregnancy through the first 2 hours after
surgery
40. Tissue factor and factor VII
activation
essential for blood clotting
Important step is
Moving from prothrombin
to Thrombin
independently of FVIII
and FIX.
This step is independent
of TF.
The thrombin burst leads
to the formation of
a stable clot
41. Temporary treatment regimen
•After obstetric interventions (constriction of RESERVED, circuit nodes)
•- If the blood continues to flow mauchay
•- Before you decide to cut styptic TC (if possible)
Dose
Second dose
Temperature normal
platelete
42. Techniques in surgical hemostasis
• Manual removal and inspection of the placenta
• Clamp pulling / twisting Cervix
• Examination of uterus, surgical repair
• Other measures
43. Hemostasis by ballon
•
•
•
sonde of Foley
sonde of Rüsch
Sonde of
Blakemore
• sonde of Linton-
Nachlas
51. Arterial embolization
• The center is equipped with
• Button-screen circuit in the operating room through brightening
due to radiologist do
Can proceed in the following cases:
• After cesarean section, after hemostatic suture lines under
• Can be conducted even when the patient has coagulopathy
52. Results of arterial embolization
(n) Succès
successful(%)
nombre (%)
Greenwood et al 6 83
Gilbert et al 10 100
Mitty et al 7 86
Yamashita et al 15 100
Merland et al 15 93
Pelage et al 37 89
Vandelet et al 15 73
53. Arterial embolization
Research effective treatment of arterial embolization at
National hospital of OG 2009-2011
17 patients were node artery at Bach Mai Hospital and Vietnam Germany
(14: bleeding after cesarean section, postpartum usually 1, 1 to abortion, after
cutting the TC 1)
100% stop bleeding, bleeding in 3 1/3 days off
No one hysterectomy
Not yet infected patients after occlusion of the vessel
1 Patients with lower extremity arthritis rules, medical treatment
100% return of menstruation
(Nguyen Phuong Tu, thesis of graduade Dr , HNU, 2012)
54. Dangerous if transfere
•State of shock not control:
•- BP drops (had a blood transfusion / catecholamine)
•- Need to control resuscitation of shock
•Not only good for the circuit node:
•- Shock bleeding during cesarean section
•- Bleeding after cesarean
•No blood and blood products
•- A rare blood type, antibodies against the human erythrocyte
•- Problem organizations
•- Prognosis: deadline to stop bleeding
55. Pregnant women treated in the ICU,
and maternal mortality
%
20
15
10
5
0
maternal death
total transfere grade III
Bouvier-Colle MH et al, Eur J Obstet Gynecol 1996,65:121-5
56. Classification of obstetric hospital
*Grade 1
•Get the patient has no risk factors
•Full-term newborn care
* Grade 2
•Get the care of patients requiring more complex
•Have neonatal department
* Grade 3
•Get the severely ill patients requiring intensive care
•Have neonatal ICU unit
57.
58.
59. Anesthesia
• Epidural anesthesia if available is sufficient for the
hemostatic surgical echniques
• Anesthetic when bleeding more
and surgery to stop bleeding
• Priority selection ketamine (1 mg / kg) or
Etomidat (0.3mg/kg)
60. Conclusion
• 87% of deaths due to bleeding that could have been avoided
• Pay attention to time detection, treatment usually late
• The discreet clinical sign
• Blood transfusion in proportion 1/1 - Fibrinogen - Transamin
• Keep progressing syndrome CIVD
• Position the insertion of the ballon, arterial embolization and
circuit activates factor VII?